Literature DB >> 1829006

The predictability of relapses in schizophrenic patients.

G Buchkremer1, K Stricker, R Holle, H Kuhs.   

Abstract

The objective of this study was to identify clinically relevant predictors of short-term (2 years) outcome in schizophrenic patients and to gather these predictors into one simple prognosis model for the course of the disease. Ninety-nine schizophrenic outpatients classified according to DSM-III criteria were observed for 3 years with regard to their relapse (rehospitalization) frequency. Predictors of both a high and a low relapse risk permitting a prognostic assessment of the individual case were based on various sources: case history data, especially those relating to the previous course of the disease: social and therapeutic situation; psychopathological findings; emotional family atmosphere; and prognosis scales.

Entities:  

Mesh:

Year:  1991        PMID: 1829006     DOI: 10.1007/bf02189543

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  33 in total

1.  [Lifestyle and age of schizophrenics. A catamnestic long-term study into old age].

Authors:  L Ciompi; C Müller
Journal:  Monogr Gesamtgeb Psychiatr Psychiatry Ser       Date:  1976

2.  Predictors of response to high dose antipsychotics in chronic schizophrenics.

Authors:  K Y Little; T L Gay; M Vore
Journal:  Psychiatry Res       Date:  1989-10       Impact factor: 3.222

3.  [Coping with the disease and disease course in schizophrenic psychoses].

Authors:  W Derissen
Journal:  Fortschr Neurol Psychiatr       Date:  1989-10       Impact factor: 0.752

4.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance.

Authors:  J Endicott; R L Spitzer; J L Fleiss; J Cohen
Journal:  Arch Gen Psychiatry       Date:  1976-06

5.  Evaluation of rehabilitation for psychotic patients in the community.

Authors:  B C Stevens
Journal:  Acta Psychiatr Scand       Date:  1973       Impact factor: 6.392

6.  Concurrent and predictive validity of thought disorder and affectivity: a 22-year follow-up of acute schizophrenics.

Authors:  R A Knight; J D Roff; J Barrnett; J L Moss
Journal:  J Abnorm Psychol       Date:  1979-02

Review 7.  [Guidelines for the psychotherapeutic management of schizophrenic patients. What do various schools and methods have in common?].

Authors:  G Buchkremer; K Windgassen
Journal:  Psychother Psychosom Med Psychol       Date:  1987-12

8.  Prediction of outcome in schizophrenia. III. Five-year outcome and its predictors.

Authors:  J S Strauss; W T Carpenter
Journal:  Arch Gen Psychiatry       Date:  1977-02

9.  [How can we give schizophrenic patients better treatment?--An integration of new pathogenic and therapeutic concepts (author's transl)].

Authors:  L Ciompi
Journal:  Nervenarzt       Date:  1981-09       Impact factor: 1.214

10.  [Disorders of premorbid social adaptation as a predictor of the 5-year prognosis of schizophrenic psychoses].

Authors:  H J Möller; W Scharl; D von Zerssen
Journal:  Nervenarzt       Date:  1984-07       Impact factor: 1.214

View more
  4 in total

1.  Self-help groups for families of schizophrenic patients: formation, development and therapeutic impact.

Authors:  H Schulze Mönking
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1994-05       Impact factor: 4.328

Review 2.  Integrity of Literature on Expressed Emotion and Relapse in Patients with Schizophrenia Verified by a p-Curve Analysis.

Authors:  Marc J Weintraub; Daniel L Hall; Julia Y Carbonella; Amy Weisman de Mamani; Jill M Hooley
Journal:  Fam Process       Date:  2016-02-15

Review 3.  Family intervention for schizophrenia.

Authors:  Fiona Pharoah; Jair Mari; John Rathbone; Winson Wong
Journal:  Cochrane Database Syst Rev       Date:  2010-12-08

4.  Predictability of rehospitalization for schizophrenia.

Authors:  J M Haro; W W Eaton; W B Bilker; P B Mortensen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.